May 16, 2018
Idorsia enrols first patient in study to test lucerastat as treatment for Fabry disease
Idorsia has enrolled the first patient in a Phase 3 registration study to investigate the effect of lucerastat, as an…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
May 10, 2018
Lilly buys ARMO for $1.6 billion
Eli Lilly will buy ARMO BioSciences for $50 per share, or approximately $1.6 billion, the companies said Thursday.
May 7, 2018
Novartis’s Alcon cares project 100 commits to reducing cataract blindness globally
Alcon, a division of Novartis, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America,…
May 3, 2018
LEH Pharma appoints Sir Henry Riley as Chairman
LEH Pharma, the provider of novel ocular implants for macular disorders, has appointed Sir Henry Riley as Chairman of the…
May 3, 2018
Hikma launches Methotrexate for Inection in USA, which sold for $13 million last year
Hikma Pharmaceuticals’s US subsidiary West-Ward Pharmaceuticals has launched Methotrexate for Injection, USP in a 1g preservative-free presentation and Methotrexate Injection,…
April 26, 2018
Concepta in a deal for myLotus delivery in China
Concepta has signed an agreement with SinoPharm, the largest state-owned pharmaceutical company in China, with annual sales of over £23…
April 24, 2018
AstraZeneca disappointed in combination of Imfinzi plus tremelimumab
AstraZeneca and MedImmune, its global biologics research and development arm, brought to public high-level results from the Phase III ARCTIC…
April 24, 2018
Sanofi’s leadership change in Research and Development
Sanofi’s Head of Global Research and Development, Elias Zerhouni, will retire from the company after more than 9 years, in the…
April 24, 2018
FDA’s Arthritis Advisory Committee recommends approval of Eli Lilly’s, Incyte Corporation’s 2-mg dose of baricitinib
Eli Lilly and Incyte Corporation scored a recommended approval of the 2-mg dose of a once-daily oral medication baricitinib from…
April 23, 2018
Beximco brings competition to Auxilium’s muscle relaxant Robaxin in USA
Beximco Pharmaceuticals has begin the export Methocarbamol tablets to the US, generic equivalent to Auxilium Pharmaceuticals’ muscle relaxant Robaxin tablets, 500mg…